Phase II study of sunitinib as second-line treatment in advanced biliary tract carcinoma: Multicenter, multinational study.

被引：3
|
作者：
Yi, J.
Thongprasert, S.
Doval, D.
Lee, J.
Cho, M. N.
Park, S. H.
Park, J. O.
Park, Y. S.
Kang, W. K.
Lim, H. Y.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Chiang Mai Univ, Chiang Mai 50000, Thailand
[3] Rajiv Gandhi Canc Inst, New Delhi, India
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Canc, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14653
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14653
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Second-line chemotherapy for advanced biliary tract cancer after failure of gemcitabine plus platinum: Results of an AGEO multicenter retrospective study.
    Brieau, Bertrand
    Dahan, Laetitia
    De Rycke, Yann
    Boussaha, Tarek
    Vasseur, Philippe
    Tougeron, David
    Lecomte, Thierry
    Coriat, Romain
    Bachet, Jean Baptiste
    Claudez, Pierre
    Zaanan, Aziz
    Soibinet, Pauline
    Desrame, Jerome
    Thirot-Bidault, Anne
    Trouilloud, Isabelle
    Mary, Florence
    Locher, Christophe
    Marthey, Lysiane
    Cacheux, Wulfran
    Lievre, Astrid
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Second-line chemotherapy for advanced biliary tract cancer: Results of a multicenter survey
    Vasile, E.
    Di Girolamo, S.
    Cereda, S.
    Lonardi, S.
    Leone, F.
    Russano, M.
    Silvestris, N.
    Vivaldi, C.
    Fornaro, L.
    Brandi, G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S614 - S614
  • [23] Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment
    Richard Kim
    E Gabriela Chiorean
    Manik Amin
    Caio Max S Rocha-Lima
    Jitendra Gandhi
    William P Harris
    Tao Song
    David Portnoy
    British Journal of Cancer, 2017, 117 : 189 - 194
  • [24] Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment
    Kim, Richard
    Chiorean, E. Gabriela
    Amin, Manik
    Rocha-Lima, Caio Max S.
    Gandhi, Jitendra
    Harris, William P.
    Song, Tao
    Portnoy, David
    BRITISH JOURNAL OF CANCER, 2017, 117 (02) : 189 - 194
  • [25] Folfiri as second-line treatment in advanced pancreatic cancer: A phase II study
    Giuliani, F.
    Mallamaci, R.
    Di Bisceglie, M.
    Galetta, D.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII158 - VII158
  • [26] Capecitabine and Nab-Paclitaxel as Second-Line Treatment for Advanced Biliary Tract Cancer (ABTC): Results from a Phase II Pilot Study
    Leighton, Carly
    Brungs, Daniel
    Sjoquist, Katrin
    Chantrill, Lorraine
    Grimison, Peter
    Tognela, Annette
    Aghmesheh, Morteza
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 127 - 127
  • [27] Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study
    Pape, Ulrich-Frank
    Kasper, Stefan
    Meiler, Johannes
    Sinn, Marianne
    Vogel, Arndt
    Mueller, Lothar
    Burkhard, Oswald
    Caca, Karel
    Heeg, Steffen
    Buechner-Steudel, Petra
    Rodriguez-Laval, Victor
    Kuehl, Anja A.
    Arsenic, Ruza
    Jansen, Holger
    Treasure, Peter
    Utku, Nalan
    CANCERS, 2020, 12 (11) : 1 - 16
  • [28] Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Di Federico, Alessandro
    Palloni, Andrea
    Carloni, Riccardo
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    Messina, Carlo
    Spallanzani, Andrea
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [29] Sunitinib malate in advanced hepatocellular carcinoma: Results of a phase II study.
    Barone, C.
    Basso, M.
    Cassano, A.
    Rufini, V.
    D'Argento, E.
    Riccardi, L.
    Schinzari, G.
    Pompili, M.
    Grieco, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] A Phase II Study of Docetaxel and Oxaliplatin for Second-Line Treatment of Urothelial Carcinoma
    Srinivas, Sandy
    Harshman, Lauren C.
    CHEMOTHERAPY, 2009, 55 (05) : 321 - 326
12345